PMA device
CorPASS System
Endotronix, Inc. · System, Hemodynamic, Implantable (MOM, Class III) · First FDA decision Dec 19, 2025, newest Dec 19, 2025Heart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
4
Naming "CorPASS"
MAUDE reports
0
Brand "CorPASS", since 2015
PubMed studies
0
Mentioning "CorPASS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing CorPASS System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- CorPASS SystemPMA supplement
P230040-S015 · Decided Dec 19, 2025 · 231 days after receipt · Normal 180 Day Track
Device type: System, hemodynamic, implantable (MOM) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "CorPASS", any status and sponsor, newest update first.
- SIRONA 2 Trial Heart Failure NYHA Class IIIActive, not recruiting
Endotronix, Inc.Not on our public-company list
NCT04012944 · 81 participants · Start Jun 26, 2019 · Primary completion Oct 30, 2021
Device: Cordella™ Pulmonary Artery Sensor System · For: Heart Failure NYHA Class III
Sites: Aalst, Belgium; Genk, Belgium; Cologne, Germany · 7 sites in all
- PROACTIVE-HF IDE Trial Heart Failure NYHA Class IIIActive, not recruiting
Endotronix, Inc.Not on our public-company list
NCT04089059 · 738 participants · Start Jan 10, 2020 · Primary completion Apr 2028
Device: Cordella™ Pulmonary Artery Sensor System · For: Heart Failure NYHA Class III
Sites: Birmingham, Alabama; Huntsville, Alabama; Phoenix, Arizona · 74 sites in all
- PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and IIIPivotal-lookingRecruiting
Endotronix, Inc.Not on our public-company list
NCT05934487 · 1,750 participants (planned) · Start Nov 29, 2023 · Primary completion Sep 2028
Device: Cordella™ Pulmonary Artery Sensor System · For: Heart Failure NYHA Class II; Heart Failure NYHA Class III; Heart Failure
Sites: Phoenix, Arizona; Los Angeles, California; San Francisco, California · 48 sites in all
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "CorPASS", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MOM
12,295 reports: 7,687 malfunction, 4,377 injury, 226 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "CorPASS"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MOM.
- CardioMEMS HF SystemAbbott Medical · PMA 2026
- Cordella Pulmonary Artery Sensor SystemEndotronix, Inc. · PMA 2026
- Cardiomems HF Pressure Measurement SystemAbbott Medical · PMA 2016
- Next Gen Patient System CM1200 CardioMEMS HERO DeviceAbbott Medical · PMA 2026
- CardioMEMS patient and hospital electronicsAbbott Medical · PMA 2018
- CardiomemsAbbott Medical · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.